C561-0417 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanamide

C561-0417 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanamide
C561-0417 Screening compound: N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C561-0417
N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C561-0417

Molecular Formula

C30H33N3O2S (C30 H33 N3 O2 S)

Compound Name

N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)propanamide

IUPAC name

(2R)-N-(1-benzylpiperidin-4-yl)-3-(benzylsulfanyl)-2-(1-oxo-23-dihydro-1H-isoindol-2-yl)propanamide

SMILES

O=C(C(CSCc1ccccc1)N(Cc1c2cccc1)C2=O)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C30H33N3O2S/c34-29(31-26-15-17-32(18-16-26)19-23-9-3-1-4-10-23)28(22-36-21-24-11-5-2-6-12-24)33-20-25-13-7-8-14-27(25)30(33)35/h1-14,26,28H,15-22H2,(H,31,34)/t28-/m0/s1

InChI Key

BIVCLUGIRLPGFT-NDEPHWFRSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

499.68

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.465

Distribution Coefficient, logD

2.907

Water Solubility, LogSw

-4.33

Polar Surface Area

43.655

Acid Dissociation Constant (pKa)

15.33

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

C561-0417 in Drug Discovery

Included in Screening Libraries

3D Mimetics PPI Library (1617 compounds)

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • Mimetics
  • 3D
Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with C561-0417 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C561-0417?
Check Price and Availability of C561-0417, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C561-0417 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C561-0417
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C561-0417
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C561-0417 available by request